Skip to main content
SpringerLink
Log in

Fresolimumab

Eine neue Therapieoption für systemische Sklerodermie am Horizont?

Fresolimumab

A new treatment option for systemic scleroderma on the horizon?

  • Journal Club
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Rice LM, Padilla CM, McLaughlin SR, Mathes A, Ziemek J, Goummih S, Nakerakanti S, York M, Farina G, Whitfield ML, Spiera RF, Christmann RB, Gordon JK, Weinberg J, Simms RW, Lafyatis R (2015) Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients. J Clin Invest 125(7):2795–2807

    Article  PubMed  Google Scholar 

  2. Farina G, Lafyatis D, Lemaire R, Lafyatis R (2010) A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 62(2):580–588

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hautklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland

    B. Homey

Authors
  1. B. Homey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Homey.

Ethics declarations

Interessenskonflikt

B. Homey gibt an, dass kein Interessenskonflikt besteht.

Dieser Beitrag beinhaltet keine Studie an Menschen oder Tieren.

Additional information

Redaktion

J. Krutmann, Düsseldorf

Redaktionelle Mitarbeit

C. Hafner, Regensburg

B. Homey, Düsseldorf

R. Gläser, Kiel

A.S. Yazdi, Tübingen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Homey, B. Fresolimumab. Hautarzt 66, 797–798 (2015). https://doi.org/10.1007/s00105-015-3684-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-015-3684-z

Search

Navigation